Physician profile
Michael Flashburg
NPI 1093712515
$1,116.44
in general payments reported to CMS, 2019-2025
14 companies · $31.13 in 2025
The $31.13 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2021: $103 · 2022: $325 · 2023: $49.36 · 2024: $139 · 2025: $31.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $205.53 | 2021-2023 | Fibryga, Balfaxar, Octaplas |
| Heron Therapeutics, INC. | $171.49 | 2022-2024 | Aponvie |
| Merck Sharp & Dohme LLC | $144.51 | 2019 | |
| Medtronic, INC. | $130.68 | 2022-2024 | Mcgrath Mac |
| Mallinckrodt Enterprises LLC | $124.99 | 2019 | |
| Comsort, INC | $100.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $63.74 | 2019-2024 | Exparel |
| Acacia Pharma INC | $42.76 | 2021 | |
| Getinge USA Sales, LLC | $37.56 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $31.13 | 2025 | |
| Masimo Corporation | $23.81 | 2019 | |
| Ethicon US, LLC | $14.39 | 2024 | Echelon Flex |
| Eagle Pharmaceuticals, INC. | $13.77 | 2023 | |
| Acelrx Pharmaceuticals, INC. | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Flashburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.